← Leaderboards
Saba Valadkhan
Case Western Reserve University
$3,043,119
Attributed
$4,172,833
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $456.4K · FY2006–23$500K$375K$250K$125K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$4,172,833 · 3
By mechanism
R01$3,736,958 · 2
R21$435,875 · 1
Top collaborators
- William Schiemann5 shared
Most similar at Case Western Reserve University
Same institution · by research overlap
- William Schiemann$12,636,493
- Maria Hatzoglou$21,481,279
- Kimberly Parker$329,928
- Xiaofeng Zhu$15,377,238
- Alex Yee-Chen Huang$8,501,439
Others in their field
Top investigators on “Mediating”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Lawrence Corey · Fred Hutchinson Cancer Center$493,822,581
- Barton F Haynes · Duke University$295,802,493
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$286,700,869
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$176,977,598
- Dan H. Barouch · Fred Hutchinson Cancer Center$122,734,499
Research focus
MediatingBaseMolecularInsightIn VivoEventComplexIn VitroHuman DiseaseMapsTranscriptomeProgramsResponseBiological ModelsPositioning AttributeProteinsUntranslated RnaEpigenetic ProcessGenesCellsArchitectureMolecular ConformationGene ExpressionApoptosis
Grant awards (13)
Role of the lncRNA BORG in Breast Cancer Metastatic Progression and Recurrence$447,306
R01 · FY2023 · CA
Role of the lncRNA BORG in Breast Cancer Metastatic Progression and Recurrence$447,306
R01 · FY2022 · CA
Role of the lncRNA BORG in Breast Cancer Metastatic Progression and Recurrence$456,435
R01 · FY2021 · CA
Role of the lncRNA BORG in Breast Cancer Metastatic Progression and Recurrence$454,781
R01 · FY2020 · CA
Role of the lncRNA BORG in Breast Cancer Metastatic Progression and Recurrence$453,600
R01 · FY2019 · CA
Defining the lncRNA-mediated cis regulatory networks that control HIV life cycle in T cells$198,125
R21 · FY2017 · AI · contact PI
Defining the lncRNA-mediated cis regulatory networks that control HIV life cycle in T cells$237,750
R21 · FY2016 · AI · contact PI
Characterization of a minimal "spliceosome"$259,909
R01 · FY2010 · GM · contact PI
Characterization of a minimal "spliceosome"$262,534
R01 · FY2009 · GM · contact PI
Characterization of a minimal "spliceosome"$159,644
R01 · FY2009 · GM · contact PI
Characterization of a minimal "spliceosome"$262,534
R01 · FY2008 · GM · contact PI
Characterization of a minimal "spliceosome"$262,534
R01 · FY2007 · GM · contact PI
Characterization of a minimal "spliceosome"$270,375
R01 · FY2006 · GM · contact PI